I received only one dose of hepatitis B vaccine one year ago; what should I do now?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Complete Your Hepatitis B Vaccination Series Now

You should resume your hepatitis B vaccination series immediately by getting your second dose now, followed by a third dose at least 8 weeks later—the series does not need to be restarted despite the one-year delay 1.

Key Guidance on Interrupted Vaccination Series

The 2022 ACIP guidelines are explicit and reassuring about your situation: if the hepatitis B vaccination schedule is interrupted, the series does not need to be restarted 1. This is critical—you don't lose the benefit of that first dose you received a year ago.

What You Should Do Next

Schedule your second dose as soon as possible. Here's the specific algorithm to follow:

  • Dose 2: Get it now (as soon as possible, regardless of the one-year delay)
  • Dose 3: Administer at least 8 weeks after dose 2
  • The final dose must be given at least 16 weeks after your first dose (which you've already exceeded) 1

Vaccine Options Available

You have several choices for completing your series:

Standard 3-dose vaccines:

  • Engerix-B or Recombivax HB: Traditional options requiring 3 doses total (0,1, and 6 months schedule when started fresh) 1
  • PreHevbrio: Newer 3-dose option 1

Alternative 2-dose option:

  • Heplisav-B: If you're ≥18 years old, you could switch to this vaccine, which only requires 2 doses given 1 month apart 1, 2. However, to count as a valid 2-dose series, both doses must be Heplisav-B 2

Important Considerations

Vaccine interchangeability: When feasible, use the same manufacturer's vaccine to complete your series. However, vaccination should not be delayed if the original vaccine brand is unknown or unavailable 2. The vaccines are interchangeable, and completing the series is more important than brand consistency 3.

Why you still have protection potential: Research demonstrates that even a single dose primes your immune system. A study showed that adults who received one or two doses years earlier mounted robust anamnestic (memory) responses when given subsequent doses 4. Your immune system "remembers" that first dose.

Common Pitfall to Avoid

Do not restart the series from scratch. This is wasteful and unnecessary. The most common error is providers restarting the entire vaccination schedule when patients present with incomplete series. Your first dose counts, and you only need to complete the remaining doses 1.

What Happens After Completion

Once you complete the series:

  • You should receive postvaccination serologic testing (anti-HBs) 1-2 months after your final dose to confirm protective antibody levels 5
  • Protective levels are defined as anti-HBs ≥10 mIU/mL 6
  • If you're a healthcare worker, this testing is particularly important for occupational health documentation 5

Bottom line: Get your second dose now, wait at least 8 weeks, then get your third dose. The year-long gap doesn't invalidate your first dose—you're simply picking up where you left off.

Related Questions

What is the correct technique for administering the hepatitis B vaccine?
What is the recommended dosing schedule and dosage of Genevac‑B (hepatitis B vaccine) for different age groups?
Should the hepatitis B vaccine be administered intramuscularly (IM) or subcutaneously (SC)?
What are the indications, dosing schedule, contraindications, pregnancy considerations, side effects, and alternative options for Engerix‑B (recombinant hepatitis B surface antigen vaccine)?
Should a 29-year-old woman with unknown hepatitis B immune status receive the hepatitis B vaccine?
What drug interaction considerations should be taken into account when prescribing Vyvanse (lisdexamfetamine) to a patient with asthma who is using inhaled corticosteroid (ICS) such as fluticasone, long‑acting beta‑2 agonist (LABA) such as salmeterol, leukotriene receptor antagonist such as montelukast, and short‑acting beta‑2 agonist (SABA) such as albuterol?
In which patients with candiduria is fluconazole indicated, and what are the appropriate dosing regimens for uncomplicated versus upper urinary tract infection?
Is a complete blood count (CBC) and comprehensive metabolic panel (CMP) sufficient to diagnose syndrome of inappropriate antidiuretic hormone secretion (SIADH)?
Is intramuscular analgesia superior to oral analgesia?
What is the appropriate management for a patient with hyperthyroidism being treated with methimazole who now has a markedly elevated thyroid‑stimulating hormone, a goiter causing dysphagia?
Do any of the following medications—gabapentin, hydroxyzine, atomoxetine (Strattera), trazodone, venlafaxine, spironolactone, norgestimate/ethinyl estradiol, bisacodyl (Dulcolax), magnesium supplement, AZO Yeast Plus, acidophilus, docusate sodium, senna, docusate (Colace), or propranolol—adversely affect a cerebrospinal fluid (CSF) leak?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.